Arash Ghaffari

Dr. Arash Ghaffari

Aalborg University Hospital, Aalborg, Nordjylland, Denmark
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Transplantation Proceedings
Verified
Journal Article
Closed access
AGA. Ghafari
A. Ghafari
JEJ. Etemadi
J. Etemadi
MAmohammadreza ardalan
mohammadreza ardalan

1 September 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
BEB. Einollahi
B. Einollahi
NSN. Simforoosh
N. Simforoosh
MLM. Lessan-Pezeshki
M. Lessan-Pezeshki
ABA. Basiri
A. Basiri
MNM. Nafar
M. Nafar
HKH. Tayebi Khosroshahi
H. Tayebi Khosroshahi

1 June 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
ASA.P. Shabanzadeh
A.P. Shabanzadeh
SSS.S. Sadr
S.S. Sadr
AGA. Ghafari
A. Ghafari
BNB.H. Nozari
B.H. Nozari
MTM. Toushih
M. Toushih

5 October 2013
Verified
Journal Article
Open access
PDF file
MAmohammadreza ardalan
mohammadreza ardalan
AGAli Ghafari
Ali Ghafari
FHFatemeh Hamzavi
Fatemeh Hamzavi
Hamid NasriHamid Nasri
Hamid Nasri
BBBehrooz Baradaran
Behrooz Baradaran
BNBehrooz Nikbin
Behrooz Nikbin
Idiopathic Membranous Nephropathy (iMN) is the most common cause of nephrotic syndrome in adults. Approximately one third of patients with iMN progress to end-stage renal disease. Anti-phospholipase A2-receptor (anti-PLA2R) antibodies are present in patients with iMN and appear to play a role in the pathogenesis of iMN. In this study, we explored the prevalence of anti-PLA2R antibodies in a cohort of patients with iMN in Iran. We also sought to determine circulating levels of anti-secretory PLA2 (anti-sPLA2) antibodies in those with anti-PLA2R antibodies. Using an indirect immunofluorescence assay, we measured anti-PLA2R antibodies in a group of patients with iMN in Iran. The serum levels of anti-sPLA2 antibodies were also measured in those with positive results for anti-PLA2R antibodies. We studied 23 patients with iMN (M/F 12/11, 34±9.8 year), two patients with secondary MN and five patients with the nephrotic syndrome of other causes.Anti-PLA2R antibodies were detected in 17/23 (74%) of patients with iMN, but not in those with secondary MN or other forms of primary glomerular diseases. We found no correlation between anti-PLA2R antibody titer and the degree of proteinuria. We found high titers of anti-sPLA2 antibodies in a subset of patients with high levels of anti-PLA2R antibodies. Anti-PLA2R antibodies are specific for iMN. Proteinuria may also reflect glomerular structural damage rather than immunological activity of the disease. The preliminary idea of any presumptive role of anti-sPLA2antibodies in iMN needs further investigation.

1 January 2008 in Transplantation Proceedings
Verified
Journal Article
Closed access
AGA. Ghafari
A. Ghafari
HSH. Sanadgol
H. Sanadgol

15 July 2022 in Sensors
Verified
Journal Article
Open access
PDF file
Arash GhaffariArash Ghaffari
Arash Ghaffari
OROle Rahbek
Ole Rahbek
RLRikke Emilie Kildahl Lauritsen
Rikke Emilie Kildahl Lauritsen
AKAndreas Kappel
Andreas Kappel
SKSøren Kold
Søren Kold
John RasmussenJohn Rasmussen
John Rasmussen
Sensors with a higher sampling rate produce higher-quality data. However, for more extended periods of data acquisition, as in the continuous monitoring of patients, the handling of the generated big data becomes increasingly complicated. This study aimed to determine the validity and reliability of low-sampling-frequency accelerometer (SENS) measurements in patients with knee osteoarthritis. Data were collected simultaneously using SENS and a previously validated sensor (Xsens) during two repetitions of overground walking. The processed acceleration signals were compared with respect to different coordinate axes to determine the test–retest reliability and the agreement between the two systems in the time and frequency domains. In total, 44 participants were included. With respect to different axes, the interclass correlation coefficient for the repeatability of SENS measurements was [0.93–0.96]. The concordance correlation coefficients for the two systems’ agreement were [0.81–0.91] in the time domain and [0.43–0.99] in the frequency domain. The absolute biases estimated by the Bland–Altman method were [0.0005–0.008] in the time domain and [0–0.008] in the frequency domain. Low-sampling-frequency accelerometers can provide relatively valid data for measuring the gait accelerations in patients with knee osteoarthritis and can be used in the future for remote patient monitoring.